Published on 16 August 2019
CEO Jussi Salminen:
“During the first half of the year, we continued to focus on the cornerstones of our chain-based business, as launched last year: building the operating conditions, developing our network of sites and profitable growth. Reviewing the first half of the year, we are delighted to see that our profitability has continued to develop in the right direction. This was the third consecutive quarter in which Silmäasema’s adjusted EBITDA has improved year-on-year.
In January–June 2019, Silmäasema’s net sales and adjusted EBITDA improved strongly during both the first and second quarters. In addition, the cashflow from operations developed strongly. The favourable development is based on an overall improvement in the performance of optical retail, which plays a decisive role with regard to the Group’s net sales. With regard to the eye clinics, we still have work to do.
In line with what we announced earlier, we have identified opportunities outside our personnel expenses to streamline our operations and optimise our cost structure. We are seeking to reduce costs gradually by around EUR 2 million by the end of 2020. The implementation of these measures has progressed faster than planned during the first half of the year.
The Optical Retail and Eye Healthcare segment improved its net sales and result markedly. The number of customers visiting our stores increased and we succeeded in serving them expertly and profitably. We will continue to actively develop our network, and we will systematically revise our store locations, opening times and the services they offer. The continuous improvement of the knowledge and skills of our experts and customer service personnel is at the core of our development efforts.
I am not satisfied with the performance of the Eye Clinics segment. Net sales and EBITDA were especially burdened by the lower sales of other services than refractive and cataract surgeries. In addition, the adjusted EBITDA was burdened by the measures implemented to increase volumes. These measures have an immediate effect on expenses, but their impact on the result typically becomes visible only over the longer term.
We have today published Silmäasema’s updated strategy and financial targets for the period 2020-2022. Silmäasema’s goal is to renew the eyesight market and grow profitably. We seek to develop into customers’ preferred good eyesight partner that comprehensively responds to their changing needs and offers the most suitable solutions for good eyesight for people of different ages, in various environments and situations and for all eye healthcare issues.
Company’s growth and profitability will be based on becoming customers’ preferred choice and the leading expert in eye healthcare, renewing and growing the eyesight market, and improving performance and profitability.
We will present the strategy and its implementation towards the end of the year, both at our Capital Markets Day on 18 September 2019, and at other investor meetings and private investor events.
I started as CEO at the beginning of 2019. Now that the first half-year has passed, I would like to take this opportunity to thank our employees for the results we have achieved together so far and our customers for their trust Silmäasema was selected as the most widely trusted optician store in Finland for the second consecutive time. Overall, we are satisfied with our first-half result and our progress in terms of our priorities for 2019.”
Published on 17 May 2019
CEO Jussi Salminen:
“Silmäasema’s net sales and adjusted EBITDA improved on the previous year in January-March. In Optical retail we succeeded well throughout the network and group’s net sales increased overall by 4.3% to EUR 32.2 million, and our like-for-like net sales grew by 1.8%. Eye Clinics suffered from lower volumes than the previous year.
As part of our development programme we have identified opportunities to streamline our operations and optimise our cost structure outside our personnel expenses. We estimate the potential impact on profit of the identified opportunities to be approximately EUR 2 million. This would be achieved gradually by the end of 2020. In part, the impact can already be seen in the result for the first quarter.
Our financial reporting was updated at the beginning of the year to comply with the IFRS 16 Leases standard and this has had an impact on, among other things, the reported and adjusted EBITDA since the beginning of the year. Reported according to the new standard, the first-quarter adjusted EBITDA was EUR 5.2 million including the EUR 1.9 million impact of the adoption of the IFRS 16 standard. Excluding the impact of the adoption of IFRS 16 standard, the adjusted EBITDA improved by 21% on the comparison period.
The Group’s cash flows from operating activities developed exceptionally well and increased almost 60% to EUR 7.0 million. The impact of the adoption of the IFRS 16 standard was EUR 1.7 million. Despite the growth of net sales and the network, our fixed costs remained at the level of the comparison period excluding the impact of the IFRS 16 standard.
In Optical Retail net sales increased by 9.5% to EUR 23.2 million. We managed to increase our sales while retaining a good gross profit margin. The segment’s adjusted EBITDA improved by 58%, excluding the effect of the adoption of the IFRS 16 standard. As we have previously communicated, we develop our network in a customer-focused manner and as the year progresses, we systematically make changes to the locations of stores, their opening times and the services they offer. The development of the network includes the evaluation of our Estonian operations as a whole in addition to our Finnish operations. Active development of the network of locations also includes store closures and openings.
The Eye Clinics segment’s net sales declined 7.2% to EUR 8.9 million and this reflected directly on the segment’s profitability. The segment’s adjusted EBITDA declined 20%, excluding the effect of the adoption of the IFRS 16 standard. In our view there has not been any significant change in the size of the total refractive and cataract surgery market in Finland. We have analysed the reasons for the decline in the number of procedures and have launched our first steps to improve the volumes. These include, among others, boosting customer acquisition, strengthening cross-selling, and developing cooperation with our doctors.
In 2019, we will focus more on improving productivity. Our priorities for the current year are improving the operational preconditions, developing our network and improving profitable growth. In addition, we have launched a strategy process during the review period, the results of which we will report more in the second half of the year.
Our staff through the organization has done a lot of work and achieved good results together in the early part of the year. As a whole, we are pleased with both the results of the early part of the year and the progress of this year's priorities.”
Published on 7 March 2019
CEO Jussi Salminen:
Silmäasema continued its controlled growth in 2018. We opened eight new optical retail stores in Finland and one in Estonia, in addition to a new eye clinic in Oulu. As previously announced, we have shifted our focus from strong network growth towards improving location-specific sales and profitability, as well as network development. With regard to this focus, we are also exploring opportunities to grow and introduce new services and business models related to good eyesight.
Silmäasema’s total net sales grew by 4.9% to EUR 32.4 million in the fourth quarter and by 3.8% to EUR 122.9 million in 2018. The Group’s adjusted EBITDA developed very favourably during the fourth quarter of 2018, increasing by 27% year-on-year to EUR 3.5 million as a result of highly successful optical retail trade. Consequently, Silmäasema’s full-year adjusted EBITDA reached the previous year’s level, EUR 11.8 million.
During the fourth quarter of 2018, the strong development of net sales and EBITDA was mainly driven by a good level of commercial success in optical retail, in addition to the positive effect of favourable development of purchase prices on the sales margin. The new eye clinic opened in Oulu in February is off to a strong start, with good net sales development during the year. The full-year adjusted EBITDA was burdened by expenses related to opening new units, in addition to net sales developing more slowly than expected during the first half of the year, particularly for new stores.
Despite the good development during the second half of the year, we cannot be satisfied with our like-for-like net sales decreasing by 1.6% in 2018. The Optical Retail segment’s like-for-like net sales decreased year-on-year in January–September, but its full-year like-for-like net sales were at the previous year’s level, thanks to strong development in October–December. In the Eye Clinics segment, procedure volumes for units opened before 2018 were lower than in the previous year, and the segment’s like-for-like net sales decreased as well. At the annual level, the number of cataract surgeries increased slightly, but the number of refractive surgeries and other procedures decreased year-on-year. We have analysed the factors explaining the weak development of our procedure volumes. To increase our volumes and strengthen our market share, we will actively develop our customer acquisition process and operating model in 2019, to name just two examples. Over the longer term, the market for optical retail and eye clinic services will grow because of the ageing population and increasing demand for health and well-being services. This will also increase demand for Silmäasema’s services.
In 2019, we will focus on improving profitability and efficiency and developing new target groups and business models. Our strategic focuses for 2019 include improving our operating conditions, developing network and improving our profitability.
During the review period, we started looking into measures that will enable us to accelerate productivity and profitability improvement in 2019–2020. A study on detailed measures is in progress, and we expect the first measures to have a visible effect on our result towards the end of 2019. We have also continued planning the information system renewals related to Silmäasema’s development programme. Our information system acquisition process started at the beginning of 2019.
Silmäasema is a Finnish expert in good eyesight. We are the largest private eye healthcare provider and the second largest chain of optical stores in Finland. We work to be the best partner for consumers and companies, as well as contributing to the development of our sector as a whole. I am inspired by this opportunity to manage Silmäasema as it responds to eye care needs in a customer-focused, innovative and profitable manner.
Published on 9 November 2018
Interim CEO Anu Kankkunen:
Silmäasema’s net sales grew during the third quarter, but the growth was slower than before and was not on the level anticipated. Our total net sales increased due to the opening of new stores and the eye clinic in Oulu, but our like-for-like net sales decreased in both reporting segments. We cannot be satisfied with this, even though fluctuation in the sales level is part of the nature of the sector. The last quarter has started with strong sales, so far the growth in October–November has been more than 10 percent.
The slow performance of net sales was also adversely affecting profitability in the review period. The Group’s adjusted EBITDA was behind last year both in Q3 and in the first nine months of 2018. With the expansion of our network, our expenses have increased as planned, but our net sales have not grown at a sufficient rate in relation to the expenses, even though our new stores continue to develop in the right direction. Lower like-for-like net sales are also weakening profitability. The second quarter of 2017 was exceptionally strong, particularly in terms of profitability, which is part of the reason for the development of the figures in January–September 2018 in relation to the comparison period.
We opened two new optical retail stores in Finland in August–September, but as we announced earlier, we are now focusing more on improving the net sales and profitability of our existing network than expanding the network. During the review period we started looking into measures that will enable us to accelerate productiveness and profitability. The work is still in progress and the impact of any measures are only likely to be visible in our results starting from next year. We have also continued planning the information system renewals related to Silmäasema’s development programme.
September the Board of Adjustment partly annulled the Tax Administration’s decision regarding the value added taxation of Silmäasema Optiikka Oy. Regarding the rejected appeals for adjustment, Silmäasema has appealed against the decision to Administrative Court. Due to the Board of Adjustment’s decision, the tax returns entered in the third quarter income statement have a clearly positive impact on Silmäasema’s result and cash flow for the 2018 financial year. However, the decision will not change the company’s outlook as Silmäasema has eliminated the impact of the change in value added tax deduction practice when reporting the adjusted EBITDA and adjusted operating result, and it will also eliminate the impact of the returned value added tax items.
Silmäasema’s outlook for 2018 remains unchanged. We estimate that our net sales will grow compared to the previous year and that our adjusted EBITDA will be 9–13% of net sales. However, our adjusted EBITDA for the full year will be closer to the lower end of this range.
Published on 17 August 2018
CEO Pasi Kohmo:
The development of Silmäasema’s net sales did not meet expectations during the first half of 2018. Our total net sales increased due to the opening of new stores and the eye clinic in Oulu, but our comparable net sales decreased. Our sales were lower than expected in both reporting segments, particularly in the second quarter, even though changes in the level of sales are part of the nature of the industry.
The slow development of net sales was also reflected in profitability. With the expansion of our network, our expenses have increased as planned, but our net sales have not grown at a sufficient rate in relation to the expenses, even though our new stores continue to develop in the right direction. This is the main reason for the decrease in our adjusted EBITDA and profitability. The decrease is enhanced by the fact that the second quarter of 2017 was very strong, particularly in terms of profitability. In the second quarter of 2018, profitability was also burdened by a weaker campaign structure in optical retail, as well as a higher proportion of cataract surgeries at our eye clinics and lower prices in comparison with the corresponding period last year, due to campaigns.
This year, we have opened a new eye clinic in Oulu and have expanded our optical retail store network with six stores in Finland and one store in Estonia. In line with our growth strategy, we continue to seek suitable new store locations for Silmäasema, but we estimate that our growth in Finland will be markedly slower than it has been in recent years. Now our focus is more strongly on improving the net sales and profitability of our existing network.
In June, the Finnish Government further specified its proposal for the Freedom of Choice Act for social and health services. The amendments were related to a longer transition period for the implementation of freedom of choice, among other aspects. The final content and implementation of the act will determine its effects on freedom of choice with regard to cataract surgeries. However, with the population ageing and the need for cataract surgeries continuously increasing, we believe that the number of cataract surgeries carried out in the private sector will continue to grow before the finalised law comes into effect. This is due to the service vouchers that have already been taken into use and the pilot projects related to the Freedom of Choice Act.
We announced earlier this year that we are in the process of starting a development program that will last for about two years. The program includes changes to operating models and the renewal of information systems. It focuses on improving existing operating models and increasing profitability with new operating methods and information system solutions that support these methods. During the second quarter, we started planning the information system renewals related to the development program. To accelerate our profitability development, we have decided to find out whether it is possible to implement the development program earlier than planned with regard to changes in operating models that are not dependent on information system renewals. We intend to focus on changes that could accelerate productivity and profitability.
Silmäasema’s outlook for 2018 remain unchanged. We estimate that our net sales will grow compared to the previous year and that our adjusted EBITDA will be 9–13% of net sales. However, after the first half of the year it seems that our adjusted EBITDA for the full year is more likely to be closer to the lower end than the higher end of the range.
Published on 17 May 2018
CEO Pasi Kohmo:
Silmäasema continued its planned growth during the first quarter of 2018 and net sales grew 4.1% to EUR 30.9 million. We opened a new eye clinic in Oulu and expanded our optical retail store network with three stores in Finland and one store in Estonia. At the end of March 2018, Silmäasema had a total of 145 own stores in Finland and Estonia, which is, in fact, 18 more stores than at the end of March 2017. Taking into consideration the rapid growth of the network and the investments required to achieve this growth, we are satisfied with the fact that in this period of considerable growth, adjusted EBITDA remained at the same level as the previous year.
In practice, the increase in net sales came from new stores that were opened in 2017–2018, stores acquired through company and business acquisitions and from the new eye clinic that was opened in Oulu in February 2018. Like-for-like net sales decreased by 2.4%. A large part of the decline is due to the timing of Easter this year, which was between the end of March and the beginning of April.
The gross profit improved due to the net sales growth, improvement in purchase prices and the optical retail sales structure that was better than in the comparative period. On account of a rise in fixed costs, mainly personnel and rent costs, the adjusted EBITDA was, however, at the same level as the previous year. A significant share of the increase in costs came from the costs of the optical retail stores that were acquired and opened in Finland in 2017 and from the costs related to operating as a listed company. There were hardly any of these types of costs in the comparative period. In addition, the review period’s fixed costs include costs related to, among others, the development of our organisation and network, and these costs will not be permanent.
Relative profitability weakened slightly from the previous year, which is mainly due to the large number of optical retail stores that were opened over the years 2016–2018. As a whole these stores reduced the relative profitability of the entire Group. New units have previously, on average, reached their normal profitability level in one to two years from start-up, but there can be significant variation in the development of individual stores. However, the profitability of stores acquired in Finland in 2017 through business acquisitions is already close to the target level. We are continuing our persistent work to ensure that the new stores reach their target level for profitability. The overall profitability of the rest of the store network was at a good level.
The net sales of the Eye Clinics segment increased slightly, mainly due to the new eye clinic that was opened in Oulu. The opening of the clinic was successful, and we now have a truly nationwide chain of eye clinics. While the number of cataract surgeries remained at the previous year’s level, the number of refractive surgeries increased from the comparative period and the previous quarter. Though we are pleased with the trend in the number of refractive surgeries during the early part of the year, it is difficult to predict the level of future demand both in refractive and cataract surgeries.
The Finnish Government submitted its proposal for the Freedom of Choice Act for social and health services to Parliament on 8 March 2018. The final content and implementation of the act will determine its effects on freedom of choice with regard to cataract surgeries. Silmäasema is committed to the goals of the Government’s health and social services reform and regional government reform. We believe that the increasing freedom of choice will support the development of cost-efficient and equal eye healthcare services. The legislative reform is an opportunity for us if it increases the number of cataract surgeries in the private sector. However, our financial targets are not dependent on or tied to this reform.
We announced earlier this year that we are in the process of starting a development program, which will last about two years, that involves changes to operating models and the renewal of information systems. The program focuses on the improvement of existing operating models and increasing profitability with new operating methods and information system solutions that support these methods. The program will generate costs while it is ongoing but procurements related to the program are likely to be booked as capital expenditure. During the first months of the year we have selected a partner through competitive bidding to design the information system renewals related to the development program. We will provide regular reports on the progress of the development program in our financial reports.
We complemented our outlook for 2018 in April, after the review period. We estimate that our net sales will grow compared to the previous year and that our adjusted EBITDA will be 9-13% of net sales.
Published on 7 March 2018
CEO Pasi Kohmo:
The year 2017 was a period of significant changes for Silmäasema. The Silmäasema chain grew by 19 stores, and our operations became international, with the acquisition of the Tallinna Optika chain in Estonia in January. In June, Silmäasema was listed on the main list of Nasdaq Helsinki.
During the year, Silmäasema expanded more rapidly than ever before in its history. We expanded our network of locations in line with our long-term growth strategy, and our comparable net sales grew. This rapid growth had a negative effect on our full-year profitability. However, overall, I am pleased with the company’s achievements in 2017. According to the results of an extensive consumer survey conducted in early 2018, Silmäasema has become the most widely trusted optician’s in Finland. In my opinion, this is an indication of the high-quality work carried out by our employees for our customers.
Our full-year net sales increased by 16.8% to EUR 118 million, and our comparable net sales grew by 3.5%. However, our adjusted EBITDA decreased by 1.6% to EUR 11.8 million. Profitability was burdened by the large number of optical retail stores acquired and opened in 2016 and 2017, with their profitability level developing more slowly than expected. In addition, the fourth quarter in the eye clinics business was clearly weaker than expected. In their early stages of operation, new stores’ results are burdened by costs related to the start-up of operations and the achievement of strong market positions, among other factors. On average, new stores reach their normal profitability level in one to two years from start-up. With regard to stores opened in 2016 in particular, the normalisation of the profitability level seems to be taking closer to two years from start-up. With regard to some stores, this development has been slowed down by unfinished infrastructure projects in progress nearby, among other factors.
As a whole, the fourth quarter of the year was disappointing for us, even though our Optical Retail and Eye Healthcare segment continued to increase its net sales significantly, and the profitability of new units improved. In terms of overall profitability, however, we did not reach our target level. In optical retail, net sales and profitability vary significantly between quarters within the year and in comparison with the previous year, depending on the efficiency and effectiveness of Silmäasema’s and its competitors’ sales promotion measures.
The net sales of the Eye Clinics segment decreased in the fourth quarter in comparison with the corresponding period in the previous year, mainly due to there being fewer refractive surgeries. Apart from normal variation, we have not identified any specific reason for the decrease in the number of surgeries, and the market situation does not seem to have weakened. According to our observations, the number of refractive surgeries has begun to increase again in early 2018.
The Finnish Government is preparing the final proposal for the Freedom of Choice Act for social and health services. The final content and implementation of the act will determine its effects on freedom of choice with regard to cataract surgeries. Silmäasema believes that the increasing freedom of choice supports the development of cost-efficient and equal eye healthcare services. The legislative reform is an opportunity for us if it increases the number of cataract surgeries in the private sector. However, our financial targets are not dependent on or tied to this reform.
Silmäasema works to continuously improve its operations and provide its customers with new products and services more productively. To best meet the productivity requirements and our customers’ needs for services in the future, we must continuously evaluate and develop our operations. This year, we are in the process of starting a significant development programme that involves changes to operating models and the renewal of information systems. Over the next two years, we will implement investments and changes that will enable the introduction of entirely new service and operating models in the near future. These investments and changes are related to the company’s key systems, such as cash register, patient information and reporting systems.
In 2018, we are continuing our work to implement Silmäasema’s growth strategy. During January and February, two stores were added to our chain in Finland and one in Estonia, and a new eye clinic was opened in Oulu. We continue to improve our profitability towards the company’s target level. The good general economic situation and the development of private consumption will lay a solid foundation for the optical trade in 2018. The demand for refractive surgeries has picked up, and the demand for cataract surgeries is supported over the short and long terms by population ageing. Based on these aspects and other factors, we expect that Silmäasema’s growth and development will continue in 2018.